Xiaoxiong Wei

1.7k citations
19 papers · 1.1k indexed · h-index 14

Impact in

    • Pharmacogenetics and Drug Metabolism
  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Drug Transport and Resistance Mechanisms
    • Cancer Treatment and Pharmacology

Papers in

    • Pharmacogenetics and Drug Metabolism 7
    • Antibiotics Pharmacokinetics and Efficacy 4
    • Eicosanoids and Hypertension Pharmacology 3

Xiaoxiong Wei

18 papers receiving 1.1k citations

Peers

Xiaoxiong Wei
Comparison fields: 5 of 94
  • Pharmacology 389
  • Oncology 589
  • Molecular Biology 479
  • Pathology and Forensic Medicine 110
  • Pharmacology 100
Replace Olaf Schaefer with:
Olaf Schaefer Japan
Mitsukazu Kitada Japan
Michael P. Pritchard United Kingdom
David B. Buckley United States
Xinning Yang United States
Frank Bohnenstengel Germany
Jean-Pierre Flinois France
Michael Török Switzerland
Verawan Uchaipichat Thailand
Yong–Hae Han United States
Xiaoxiong Wei relative to Olaf Schaefer Japan Olaf Schaefer's profile →
Citations per field
00.5×2.6×
Olaf Schaefer · 1×
Citations per year

Countries citing papers authored by Xiaoxiong Wei

Since Specialization
Citations

This map shows the geographic impact of Xiaoxiong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiong Wei more than expected).

Fields of papers citing papers by Xiaoxiong Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiong Wei. The network helps show where Xiaoxiong Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoxiong Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoxiong Wei Line = papers co-authored together Xiaoxiong Wei links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20210
2 202014
3 201641
4 20088
5 2002266
6 199915
7 199875
8 199819
9 1998135
10 199827
11 1998105
12 199728
13 1996274
14 199611
15 199514
16 199524
17 19957
18 19932
19 199122

About Xiaoxiong Wei

Xiaoxiong Wei is a scholar working on Pharmacology, Biochemistry, Pharmaceutical Science, Analytical Chemistry and Pharmacology, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Biochemical and Molecular Research (5 papers), Cancer therapeutics and mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Pharmacology (389 citations), Oncology (589 citations), Molecular Biology (479 citations), Pathology and Forensic Medicine (110 citations) and Pharmacology (100 citations). Xiaoxiong Wei has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Frank J. Gonzalez, Pedro M. Fernández‐Salguero, Howard L. McLeod, Soraya Madani, Kellie S. Reynolds, Shiew‐Mei Huang, Andrea Sapone, Robert E. Vestal, Hannu Raunio and Guillermo Elizondo. Their work appears in journals such as British Journal of Clinical Pharmacology, Drug Metabolism and Disposition, British Journal of Cancer, Journal of Pharmacology and Experimental Therapeutics and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026